ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Daniel M. Halperin
Matched on ORCID iD 0000-0002-3113-930X; OpenAlex author ID A5012619170.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 1, last author 0)
- Pancreatic cancer trials
- 2 (principal investigator on 2)
- Pancreatic cancer grants
- 0
- Collaborators
- 12
2014: 1 paper, 1 trial · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 trial
Papers 2
- Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy. Co-author DOI 10.1097/mpa.0000000000000914↗
- Resectable, borderline resectable, and locally advanced pancreatic cancer: what does it matter? First author DOI 10.1007/s11912-013-0366-9↗
Trials 2
Closest collaborators
The 12 strongest of 12 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Gauri Rajani Varadhachary · 2 shared papers, 2014–2017
- Ignacio Ivan Wistuba Oyarzun · 1 shared paper, 2017
- Matthew H. G. Katz · 1 shared paper, 2017
- Jennifer Brooke Goldstein · 1 shared paper, 2017
- Huamin Wang · 1 shared paper, 2017
- Reza Nejati · 1 shared paper, 2017
- Hua Wang · 1 shared paper, 2017
- Robert A. Wolff · 1 shared paper, 2017
- Jorge M. Blando · 1 shared paper, 2017
- Jason B. Fleming · 1 shared paper, 2017
- Anirban Maitra · 1 shared paper, 2017
- Jeffrey E. Lee · 1 shared paper, 2017
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.